Literature DB >> 6034239

Treatment of data from drug urinary excretion.

B K Martin.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 6034239     DOI: 10.1038/214247a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Polymorphism of carbon oxidation of drugs and clinical implications.

Authors:  T P Sloan; A Mahgoub; R Lancaster; J R Idle; R L Smith
Journal:  Br Med J       Date:  1978-09-02

2.  Comparative pharmacokinetics and metabolism of cephapirin in laboratory animals and humans.

Authors:  B E Cabana; D R van Harken; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

Review 3.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

4.  Primary, secondary, and tertiary metabolite kinetics.

Authors:  M V St-Pierre; X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

Review 5.  A review of metabolite kinetics.

Authors:  K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

6.  Determinants of the diuretic response to furosemide in infants with congestive heart failure.

Authors:  T P Green; B L Mirkin
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

7.  The kinetics of the urinary excretion of the N-oxide and glucuronides of methaqualone in man.

Authors:  K Wilson; D Burnett; M Oram; C T Reynolds
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.